Market Overview

Verastem Boosted After Positive Top-Line Data For Leukemia Treatment


Verastem Inc (NASDAQ: VSTM) shares are trading higher by $1.14 (30 percent) at $4.99 in Wednesday's session.

The catalyst for the rally is the announcement of positive top-line data from the Pivot Phase 3 DUO study for the treatment of certain types of Leukemia and Lymphoma.

Its much higher opening print is only 2 cents from the session high of $5.55. That marks the first time the stock has traded over $5.00 since September 25, 2015, when it peaked at $6.00. Profit-takers have come into the stock and nudged it lower with $4.83 standing as the low for the day as of 1:10 p.m. EST.

It's also attempting to post its first close over $5.00 since September 25, 2015, when it ended that session at $5.67.

Posted-In: Technicals Intraday Update Movers Trading Ideas


Related Articles (VSTM)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial
Book A Demo
Learn How You Can Succeed In The Market With Benzinga Pro

Fastest Market News

Real-Time News Alerts

Customizable News Filters

Book A Demo

Insurance Sector: Massive Bets Placed On Massive Damage

Exxon Mobil Upgraded As Shares Draw Close To Year-Lows